相似文献
1
Natriuretic peptides in cardiovascular diseases.
Cell Mol Biol Lett. 2008;13(2):155-81. doi: 10.2478/s11658-007-0046-6. Epub 2008 Apr 10.
2
The heart, an endocrine gland: Natriuretic peptides.
Ann Endocrinol (Paris). 2022 Feb;83(1):59-62. doi: 10.1016/j.ando.2021.11.006. Epub 2021 Dec 3.
3
Cardiovascular effects of natriuretic peptides and their interrelation with endothelin-1.
Cardiovasc Drugs Ther. 2003 Jan;17(1):41-52. doi: 10.1023/a:1024255808831.
4
Natriuretic peptides in septic patients.
Curr Med Chem. 2009;16(30):4020-31. doi: 10.2174/092986709789352330.
5
Natriuretic peptides and the dialysis patient.
Semin Dial. 2005 Sep-Oct;18(5):409-19. doi: 10.1111/j.1525-139X.2005.17349.x.
6
Dendroaspis natriuretic peptide binds to the natriuretic peptide clearance receptor.
Biochem Biophys Res Commun. 2007 Jun 22;358(1):145-9. doi: 10.1016/j.bbrc.2007.04.079. Epub 2007 Apr 19.
7
Electrophysiological effects of natriuretic peptides in the heart are mediated by multiple receptor subtypes.
Prog Biophys Mol Biol. 2016 Jan;120(1-3):37-49. doi: 10.1016/j.pbiomolbio.2015.12.001. Epub 2015 Dec 15.
8
Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.
Am J Hypertens. 2008 Jul;21(7):733-41. doi: 10.1038/ajh.2008.174. Epub 2008 May 8.
9
10
Natriuretic peptide system: physiology and clinical utility.
Curr Opin Crit Care. 2004 Oct;10(5):336-41. doi: 10.1097/01.ccx.0000135513.26376.4f.
引用本文的文献
1
Clinical Value of Circulating Microribonucleic Acids miR-1 and miR-21 in Evaluating the Diagnosis of Acute Heart Failure in Asymptomatic Type 2 Diabetic Patients.
Biomolecules. 2019 May 17;9(5):193. doi: 10.3390/biom9050193.
2
Dyspnoea with normal B-type natriuretic peptide level: don't miss cardiac tamponade! A case report.
Eur Heart J Case Rep. 2017 Oct 13;1(1):ytx003. doi: 10.1093/ehjcr/ytx003. eCollection 2017 Aug.
3
Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview.
Arch Med Sci. 2018 Jun;14(4):890-909. doi: 10.5114/aoms.2018.76279. Epub 2018 Jun 11.
4
N-terminal pro-brain natriuretic peptide and cardiovascular or all-cause mortality in the general population: A meta-analysis.
Sci Rep. 2017 Jan 30;7:41504. doi: 10.1038/srep41504.
5
Effects of immobilizations stress with or without water immersion on the expression of atrial natriuretic peptide in the hearts of two rat strains.
Am J Transl Res. 2016 Jul 15;8(7):3148-58. eCollection 2016.
6
N-terminal pro b-type natriuretic peptide (NT-pro-BNP) -based score can predict in-hospital mortality in patients with heart failure.
Sci Rep. 2016 Jul 14;6:29590. doi: 10.1038/srep29590.
7
Correlation between B type natriuretic peptide and metabolic risk factors.
Arch Med Sci. 2016 Apr 1;12(2):334-40. doi: 10.5114/aoms.2015.57001. Epub 2016 Jan 12.
8
Cardiac biomarkers in the intensive care unit.
Ann Intensive Care. 2012 Mar 7;2:8. doi: 10.1186/2110-5820-2-8.
9
Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides.
J Mol Med (Berl). 2012 Jan;90(1):5-13. doi: 10.1007/s00109-011-0801-z. Epub 2011 Aug 9.
10
Plasmid-encoded NP73-102 modulates atrial natriuretic peptide receptor signaling and plays a critical role in inducing tolerogenic dendritic cells.
Genet Vaccines Ther. 2011 Jan 10;9(1):3. doi: 10.1186/1479-0556-9-3.
本文引用的文献
1
[Endothelial dysfunction in hypertension. The role of natriuretic peptides and endothelin].
Kardiol Pol. 2005 Oct;63(4 Suppl 2):S457-61.
2
Carvedilol modifies antioxidant status of patients with stable angina.
Cell Mol Biol Lett. 2008;13(2):230-9. doi: 10.2478/s11658-007-0049-3. Epub 2008 Apr 10.
3
The concentration of atrial and brain natriuretic peptide in patients with idiopathic hypertension.
Med Sci Monit. 2007 Oct;13(10):CR449-56.
4
Plasma endothelin-1 levels in septic patients.
J Intensive Care Med. 2007 Jul-Aug;22(4):232-9. doi: 10.1177/0885066607301444.
5
Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.
Clin Exp Hypertens. 2007 Apr;29(3):149-64. doi: 10.1080/10641960701361593.
6
ANP is cleared much faster than BNP in patients with congestive heart failure.
Eur J Clin Pharmacol. 2007 Jul;63(7):699-702. doi: 10.1007/s00228-007-0309-1. Epub 2007 May 4.
7
Use of natriuretic peptides in clinical decision-making for patients with non-ST-elevation acute coronary syndromes.
Am Heart J. 2007 Apr;153(4):450-3. doi: 10.1016/j.ahj.2007.02.012.
8
Relevance of molecular forms of brain natriuretic peptide for natriuretic peptide research.
Hypertension. 2007 May;49(5):971-3. doi: 10.1161/HYPERTENSIONAHA.107.087254. Epub 2007 Mar 19.
9
NT-proBNP levels correlate with organ failure in septic patients: a preliminary report.
Postepy Hig Med Dosw (Online). 2006;60:632-6.
10
N-terminal brain natriuretic propeptide levels correlate with procalcitonin and C-reactive protein levels in septic patients.
Cell Mol Biol Lett. 2007;12(2):162-75. doi: 10.2478/s11658-006-0062-y. Epub 2006 Dec 6.
Zotero 插件